QA: Acer Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001069308_2022_Acer_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001069308, Acer Therapeutics Inc

  xvar xval
0 AssetsCurrent 28,088,616
1 IntangibleAssetsNetIncludingGoodwill 7,647,267
2 PropertyPlantAndEquipmentNet 114,112
3 remainder_Assets 406,956
4 LiabilitiesCurrent 29,109,950
5 LiabilitiesNoncurrent 209,497
6 remainder_Liabilities 8,661,109
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,756,702
9 ResearchAndDevelopmentExpense 6,935,643
10 remainder_Expenses 0
11 remainder_Revenues 1,260,000
12 remainder_NetIncome 554,984
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 36,256,951
1 Liabilities 37,980,556
2 Expenses 17,692,345
3 Revenues 1,260,000
4 StockholdersEquity -1,723,605
5 NetIncome -15,877,361
6 ComprehensiveNetIncome -15,877,361
7 BaseVar 46,872,418
8 EconomicCapitalRatiobeforeLimitedLiability -0.529
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution

Change over Time